Beckman Coulter, Inc.
Beckman Coulter – Early Sepsis Indicator
A first-of-its-kind, hematology-based cellular biomarker, the FDA cleared Early Sepsis Indicator is designed to help emergency department physicians identify patients with sepsis or at risk of developing sepsis within 12 hours of ED presentation.
- Results are automatically reported as part of a routine complete blood count (CBC) with differential for adult emergency department patients
- Combined with clinical signs and symptoms and WBC results, the Early Sepsis Indicator can inform critical decision making in adults in the emergency care setting